跳至主要内容
临床试验/CTRI/2026/04/109073
CTRI/2026/04/109073尚未招募不适用

To Study De Ritis Ratio In Patients With Sepsis Admitted In Kle Dr.Prabhakar Kore Hospital& Mrc

Jawaharlal Nehru Medical College1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2026年5月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
63
试验地点
1

研究概览

简要总结

Sepsis, defined as life-threatening organ dysfunction resulting from a dysregulated host response to infection, continues to represent a significant clinical challenge in critical care medicine. Despite advances in antimicrobial therapy and supportive care, severe sepsis is associated with high morbidity and mortality rates, underscoring the urgent need for reliable biomarkers that can facilitate early risk stratification and guide therapeutic decision-making.

The De Ritis ratio, calculated as the serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio, has long been utilized in hepatology to distinguish between various patterns of liver injury. However, emerging evidence suggests that this ratio may also serve as a prognostic indicator in a range of systemic conditions, including malignancies, cardiovascular disorders, and infectious diseases. Its utility in the context of sepsis, particularly as a marker of disease severity and outcome prediction, is a promising area of investigation

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Adult Patients above 18Years Diagnosed with sepsis according to Sepsis 3 criteria on admission.

排除标准

  • 1.Patients With Known Case Of Chronic Liver Disease 2.Patients With Known Of Kidney Disease 3.Patients With Known ase of Hematological Malignancy 4.Patients with Known case Of Inherited Metabolic Disorde 5.Patients With Known Case Of Heart Failure 6.Patients with Known Case of Autoimmune Disease 7.Patients Undergone Massive Blood Transfusion.

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Divya Sree Durga Muddamsetty

Jawaharlal Nehru Medical College,Belagavi 590010

研究点 (1)

Loading locations...

相似试验